Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics of paclitaxel administered in combination with cisplatin, etoposide and bleomycin in patients with advanced solid tumours.
Nannan Panday VR, de Wit R, Schornagel JH, Schot M, Rosing H, Lieverst J, ten Bokkel Huinink WW, Schellens JH, Beijnen JH. Nannan Panday VR, et al. Among authors: schornagel jh. Cancer Chemother Pharmacol. 1999;44(4):349-53. doi: 10.1007/s002800050988. Cancer Chemother Pharmacol. 1999. PMID: 10447584 Clinical Trial.
Hypersensitivity reactions to etoposide.
Hoetelmans RM, Schornagel JH, ten Bokkel Huinink WW, Beijnen JH. Hoetelmans RM, et al. Among authors: schornagel jh. Ann Pharmacother. 1996 Apr;30(4):367-71. doi: 10.1177/106002809603000409. Ann Pharmacother. 1996. PMID: 8729891 Review.
Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer.
Helgason HH, Kruijtzer CM, Huitema AD, Marcus SG, ten Bokkel Huinink WW, Schot ME, Schornagel JH, Beijnen JH, Schellens JH. Helgason HH, et al. Among authors: schornagel jh. Br J Cancer. 2006 Oct 9;95(7):794-800. doi: 10.1038/sj.bjc.6603332. Epub 2006 Sep 12. Br J Cancer. 2006. PMID: 16969354 Free PMC article. Clinical Trial.
The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis.
van der Wall E, Schaake-Koning CC, van Zandwijk N, Baars JW, Schornagel JH, Richel DJ, Rutgers EJ, Borger JH, Beijnen JH, Rodenhuis S. van der Wall E, et al. Among authors: schornagel jh. Eur J Cancer. 1996 Aug;32A(9):1490-7. doi: 10.1016/0959-8049(96)00129-3. Eur J Cancer. 1996. PMID: 8911107 Clinical Trial.
132 results